SCHEMBL17011998

SCHEMBL17011998

CS(=O)(=O)c1ccc(N2CCC(CNC(=O)c3cccc(C=O)n3)CC2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 2/20 0.46
CKS1B P61024 1/20 0.46
SKP1 P63208 1/20 0.46
SKP2 Q13309 1/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.46
KDM4E B2RXH2 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
HTT P42858 1/20 0.44
HSD11B1 P28845 2/20 0.43
F10 P00742 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
GPR119 Q8TDV5 4/20 0.42
TPSAB1 Q15661 2/20 0.41
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8208875 0.85 LMNA (0.48) LMNASMN1; SMN2HPGDPOLBCKS1B
SCHEMBL8208262 0.76 CHRM4 (0.47) LMNASMN1; SMN2HPGDPOLBCKS1B
SCHEMBL5776667 0.69 GPR119 (0.51) F10GPR119CTSBCTSSCTSK
SCHEMBL8201048 0.69 USP30 (0.47) LMNASMN1; SMN2HPGDPOLBALDH1A1
SCHEMBL8212238 0.69 F10 (0.49) HSD11B1F10
SCHEMBL8208874 0.67 PDGFRB (0.43) LMNASMN1; SMN2HPGDPOLBCKS1B
SCHEMBL24151174 0.67 P2RX7 (0.51)
SCHEMBL27712450 0.65 GPR119 (0.50) LMNASMN1; SMN2HPGDCKS1BSKP1
SCHEMBL13465197 0.65 CNR1 (0.52) LMNACKS1BSKP1SKP2MEN1
SCHEMBL12469013 0.65 PRKCQ (0.53) CKS1BSKP1SKP2HSD11B1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2132178-B1 JNK INHIBITORS MERCK SHARP & DOHME (US) 2015-08-19 EP disclosed
US-8975389-B2 Nucleic acid chemical modifications ALNYLAM PHARMACEUTICALS, INC. (US) 2015-03-10 US disclosed